Zai-mei Peng1, E-sheng Wu. 1. Department of Respiratory Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Abstract
OBJECTIVE: To investigate the clinical value of the 50% hypertonic glucose injection in the treatment of recurrent pneumothorax. METHODS: Forty-five patients with recurrent pneumothorax were injected with 60-80 ml of 50% hypertonic glucose into the pleural cavity after air discharge and then were instructed to turn their body to the right and the left quickly. RESULTS: The curative rate was 100% and the curative effect was satisfactory. There was no other complication except for slight stimulative chest pain in 7 patients. The recurrent rate was 4.4% in a 2-7 year follow-up. CONCLUSION: Treating recurrent pneumothorax with the 50% hypertonic glucose injection is safe, effective, and less recurrent.
OBJECTIVE: To investigate the clinical value of the 50% hypertonic glucose injection in the treatment of recurrent pneumothorax. METHODS: Forty-five patients with recurrent pneumothorax were injected with 60-80 ml of 50% hypertonic glucose into the pleural cavity after air discharge and then were instructed to turn their body to the right and the left quickly. RESULTS: The curative rate was 100% and the curative effect was satisfactory. There was no other complication except for slight stimulative chest pain in 7 patients. The recurrent rate was 4.4% in a 2-7 year follow-up. CONCLUSION: Treating recurrent pneumothorax with the 50% hypertonic glucose injection is safe, effective, and less recurrent.